Saturday, January 26, 2019 8:10:01 AM
Jan 25th, 2019
https://www.modernreaders.com/news/2019/01/25/yield10-bioscience-yten-now-covered-by-national-securities.html
Yield10 Bioscience logoInvestment analysts at National Securities initiated coverage on shares of Yield10 Bioscience (NASDAQ:YTEN) in a report issued on Wednesday, The Fly reports. The brokerage set a “buy” rating and a $5.00 price target on the specialty chemicals company’s stock.
Commercial Relationships In Early Stages. Since late 2017, two research license agreements have been reached with Monsanto and Forage Genetics International, major players in the soybean and sorghum markets, respectively. While these are research agreements for now, we believe these announcements validate Yield10’s technology and represent the kind of relationships that could generate commercial revenue.
High Ceiling Value. Between the value of the IP portfolio in the near term, and the potential value provided by commercial revenue streams, we believe shares of Yield10 could prove to be materially undervalued at current levels. Should commercialization agreements materialize, we believe our twelve month price target could prove to be conservative.”
Recent YTEN News
- Yield10 Bioscience Announces 1-for-24 Reverse Stock Split • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:01:07 PM
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 • GlobeNewswire Inc. • 03/28/2024 08:01:20 PM
- Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada • GlobeNewswire Inc. • 03/26/2024 12:29:24 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States • GlobeNewswire Inc. • 03/21/2024 12:29:14 PM
- Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests • GlobeNewswire Inc. • 02/29/2024 01:31:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:37:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 03:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:29:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:26:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:25:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 05:45:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 04:34:18 PM
- Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock • GlobeNewswire Inc. • 02/14/2024 02:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:19:22 PM
- Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program • GlobeNewswire Inc. • 02/07/2024 10:40:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:47:54 AM
- Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil • GlobeNewswire Inc. • 01/08/2024 01:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:35:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:29:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:11:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:27:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:59:53 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States • GlobeNewswire Inc. • 11/15/2023 01:32:19 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States • GlobeNewswire Inc. • 11/15/2023 01:31:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM